Lifileucel (Amtagvi) is an approved tumor-infiltrating lymphocyte (TIL) therapy for patients with advanced melanoma, but there are limited data on treatment of patients with brain ...

Oncopatch represents a meaningful addition to the treatment landscape for skin cancer…particularly in situations where ...

Metropolitan Dermatology is proud to announce the opening of its newest office in Williamstown, New Jersey, marking the practice's 23rd location and expanding access to high-quality dermatologic care ...

Biomedical scientist Dr Judey Pretorius argues that your skin shouldn’t reveal your struggle, but for millions in South Africa, it does. From harmful creams in informal markets to clinics that can’t ...

Meet 5 hot biotechs in Arizona, from Phoenix to Tucson, that have raised significant funding over the past decade.

After a Stage 1B melanoma diagnosis, Troy Regional education coordinator Whitney Barron traveled to Washington, D.C., to share her story and push for greater melanoma awareness.

“When we talk about recurrence of melanoma, we actually worry more about what we cannot see, what's on the inside,” Dr. Justine V. Cohen of the Dana-Farber Cancer Institute told CURE®. Patients with ...

OncoPatch announced today that it received FDA 510(k) for its Oncopatch Surface brachytherapy system for treating localized tumors.

A complete report of injuries and any related surgeries for all Minor League players entering the 2026 season.